Breaking New Ground: Verb Biotics' GABA Probiotic, LP815™ Shows Remarkable Benefits for Companion Animals

As pet owners increasingly seek natural, science-backed solutions for behavioral concerns like anxiety and aggression, innovative microbiome-based interventions are gaining attention.

BOULDER, Colo., Feb. 18, 2025 /PRNewswire/ -- Verb Biotics LLC, a biotech company at the forefront of microbiome innovation, has completed a groundbreaking clinical trial demonstrating the powerful behavioral benefits of its GABA Probiotic, LP815™ in companion animals. The study revealed remarkable improvements in pet behavior, positioning LP815 as a game-changing, natural solution for reducing anxiety and aggression in dogs.

The 35-day trial included a diverse group of dogs, representing 23 different breeds, all of whom exhibited existing behavioral concerns. The study leveraged two independent data sources, including a wearable fitness device, to objectively measure changes in behavior, as well as a certified owner questionnaire. The results demonstrated statistically significant reductions in anxiety and aggression, highlighting GABA Probiotic, LP815 as a promising solution for promoting calming behavior in dogs with pre-existing behavioral issues.

Beyond behavioral shifts, the study also revealed improvements in sleep quality—another key marker of overall well-being. Dogs receiving GABA Probiotic, LP815 experienced more consistent sleep patterns and higher morning energy levels, indicating enhanced restfulness. These findings suggest that LP815 not only helps reduce anxiety and aggression but also promotes more restorative sleep, potentially leading to a calmer and more resilient emotional state in dogs.

"These results mark an exciting advancement in probiotic applications for companion animal health," said Todd Beckman, CEO of Verb Biotics. "By harnessing the power of function-specific biotics, like our GABA Probiotic, we can offer pet owners a natural and effective option for supporting their pets' emotional well-being."

This groundbreaking study reinforces the growing body of evidence supporting the role of the gut microbiome in behavioral health—not just in humans, but in our pets as well. As more pet owners seek science-backed, non-pharmaceutical solutions for anxiety and behavioral concerns, Verb Biotics' GABA Probiotic, LP815 presents a novel, microbiome-driven approach to wellness. Building on these compelling findings, Verb Biotics is driving innovation in companion animal health, exploring new opportunities to enhance pet well-being through microbiome science.

About Verb Biotics 

Verb Biotics is a leading B2B ingredient supplier specializing in pro, post, and synbiotics for food, beverage, and dietary supplement brands. To learn more about Verb's innovative solutions, please visit www.verbbiotics.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/breaking-new-ground-verb-biotics-gaba-probiotic-lp815-shows-remarkable-benefits-for-companion-animals-302379287.html

SOURCE Verb Biotics